AU Stock MarketDetailed Quotes

ACWOC Actinogen Medical Ltd

Watchlist

0.007
0.0000.00%

20min DelayMarket Closed Nov 28 11:15 AET

0Market Cap0.00P/E (Static)

Actinogen Medical Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Total revenue

Cost of revenue

Gross profit

Operating expense

46.08%23.19M

20.49%15.87M

123.13%13.17M

-33.75%5.9M

8.91M

Selling and administrative expenses

10.16%7.24M

44.09%6.57M

46.51%4.56M

40.55%3.11M

--2.21M

-General and administrative expense

10.16%7.24M

44.09%6.57M

46.51%4.56M

40.55%3.11M

--2.21M

Research and development costs

74.56%15.54M

8.34%8.9M

241.40%8.21M

-56.54%2.41M

--5.54M

Depreciation amortization depletion

2.77%416.83K

1.23%405.61K

3.61%400.67K

-6.35%386.7K

--412.93K

-Depreciation and amortization

2.77%416.83K

1.23%405.61K

3.61%400.67K

-6.35%386.7K

--412.93K

Other operating expenses

----

--748.55K

Operating profit

-46.08%-23.19M

-20.49%-15.87M

-123.13%-13.17M

33.75%-5.9M

-8.91M

Net non-operating interest income (expenses)

-23.80%266.73K

1,449.40%350.06K

373.45%22.59K

-92.68%4.77K

65.18K

Non-operating interest income

-20.63%291.02K

792.71%366.65K

51.61%41.07K

-71.20%27.09K

--94.06K

Non-operating interest expense

46.35%24.29K

-10.17%16.6K

-17.20%18.48K

-22.73%22.32K

--28.88K

Other net income (expenses)

107.02%9.88M

30.58%4.77M

84.14%3.65M

-43.58%1.98M

3.52M

Other non-operating income (expenses)

107.02%9.88M

30.58%4.77M

84.14%3.65M

-43.58%1.98M

--3.52M

Income before tax

-21.32%-13.04M

-13.21%-10.75M

-142.59%-9.5M

26.55%-3.92M

-5.33M

Income tax

Earnings from equity interest net of tax

Net income

-21.32%-13.04M

-13.21%-10.75M

-142.59%-9.5M

26.55%-3.92M

-5.33M

Net income continuous operations

-21.32%-13.04M

-13.21%-10.75M

-142.59%-9.5M

26.55%-3.92M

---5.33M

Noncontrolling interests

Net income attributable to the company

-21.32%-13.04M

-13.21%-10.75M

-142.59%-9.5M

26.55%-3.92M

-5.33M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-21.32%-13.04M

-13.21%-10.75M

-142.59%-9.5M

26.55%-3.92M

-5.33M

Diluted earnings per share

Basic earnings per share

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Total revenue
Cost of revenue
Gross profit
Operating expense	46.08%23.19M	20.49%15.87M	123.13%13.17M	-33.75%5.9M	8.91M
Selling and administrative expenses	10.16%7.24M	44.09%6.57M	46.51%4.56M	40.55%3.11M	--2.21M
-General and administrative expense	10.16%7.24M	44.09%6.57M	46.51%4.56M	40.55%3.11M	--2.21M
Research and development costs	74.56%15.54M	8.34%8.9M	241.40%8.21M	-56.54%2.41M	--5.54M
Depreciation amortization depletion	2.77%416.83K	1.23%405.61K	3.61%400.67K	-6.35%386.7K	--412.93K
-Depreciation and amortization	2.77%416.83K	1.23%405.61K	3.61%400.67K	-6.35%386.7K	--412.93K
Other operating expenses	----	----	----	----	--748.55K
Operating profit	-46.08%-23.19M	-20.49%-15.87M	-123.13%-13.17M	33.75%-5.9M	-8.91M
Net non-operating interest income (expenses)	-23.80%266.73K	1,449.40%350.06K	373.45%22.59K	-92.68%4.77K	65.18K
Non-operating interest income	-20.63%291.02K	792.71%366.65K	51.61%41.07K	-71.20%27.09K	--94.06K
Non-operating interest expense	46.35%24.29K	-10.17%16.6K	-17.20%18.48K	-22.73%22.32K	--28.88K
Other net income (expenses)	107.02%9.88M	30.58%4.77M	84.14%3.65M	-43.58%1.98M	3.52M
Other non-operating income (expenses)	107.02%9.88M	30.58%4.77M	84.14%3.65M	-43.58%1.98M	--3.52M
Income before tax	-21.32%-13.04M	-13.21%-10.75M	-142.59%-9.5M	26.55%-3.92M	-5.33M
Income tax	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-21.32%-13.04M	-13.21%-10.75M	-142.59%-9.5M	26.55%-3.92M	-5.33M
Net income continuous operations	-21.32%-13.04M	-13.21%-10.75M	-142.59%-9.5M	26.55%-3.92M	---5.33M
Noncontrolling interests
Net income attributable to the company	-21.32%-13.04M	-13.21%-10.75M	-142.59%-9.5M	26.55%-3.92M	-5.33M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-21.32%-13.04M	-13.21%-10.75M	-142.59%-9.5M	26.55%-3.92M	-5.33M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data